WHO official warns world to prepare for new diseases

28 May 2006

Shigeru Omi, World Health Organization regional director for the Western Pacific, speaking at a Hong Kong press conference, has warned countries to learn from the experience of the 2002-3 severe acute respiratory syndrome outbreak in order to be ready for new and possibly more deadly diseases in the future. Dr Omi said: "as we have already seen with avian influenza, the threat from emerging diseases did not end with SARS."

Another lesson from SARS, Dr Omi said, was that transparency always is the best policy. "Because the outside world was not informed of what was going on in the initial stages of the outbreak, the virus managed to reach a tourist hotel in Hong Kong. From that moment on, international outbreak was inevitable. If we had known more about what was happening in those early weeks, things would probably have been different," he said.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight